Alcidion acquires Silverlink Software

Alcidion Group Ltd. (ASX:ALC) has acquired Silverlink PCS Software Limited.

Alcidion is transforming healthcare with smart, intuitive technology solutions that provide real-time clinical decision support. The group integrates with EMR providers and assists doctors and nurses, covering functions such as streamlining patient journeys, smart analytics to help with clinical decisions, improving patient safety and productivity amongst clinical staff through messaging applications, and data capture and interpretation.

Silverlink is one of the largest and last remaining specialist patient administration system (PAS) providers servicing the UK NHS market. It is recognized as being a flexible, cost-effective PAS that can easily integrate with other clinical systems to support a specialist modular system approach, enabling the benefits of a full electronic patient record (EPR/EMR) without single supplier lock-in.

Oaklins’ team in Australia acted as M&A corporate advisor to Alcidion Group Ltd. on the acquisition of Silverlink Software.

Service

M&A buy-side

Parties

“This is the second acquisition Oaklins has advised Alcidion on over the past 18 months. It has played a key role in the successful completion of both transactions. Oaklins consistently provided professional and commercial advice over the course of the transaction, which enabled us to navigate any deal issues that arose. Oaklins and its experienced team continue to show a deep understanding of the industry and remain a key strategic advisor to our company.”

Kate Quirke

Group Managing Director, Alcidion Group Limited

Talk to the deal team

Scott McInnes

Managing Director

Melbourne, Australia
Oaklins Henslow

View profile Get in touch

Sebastian Bell

Director

Sydney, Australia
Oaklins Henslow

View profile Get in touch

Related deals

MEDIK Hospital Design Group has been acquired by STERIS

Construction & Engineering Services | Healthcare

MEDIK Hospital Design Group has been acquired by STERIS

The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.

Learn more

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Healthcare

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.

Learn more

Banook, backed by Motion Equity, has acquired Fluidda

Healthcare | TMT

Banook, backed by Motion Equity, has acquired Fluidda

Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.

Learn more